MedPath

sodium pyruvate therapy for the patients with citrin deficiency

Not Applicable
Recruiting
Conditions
citrin deficiency
Registration Number
JPRN-UMIN000004290
Lead Sponsor
Working group for citrin deficiency
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1) pregnant woman

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adult onset type II citrullinemia (16 weeks later): 1) improvement of citrullinemia and hyperannmonemia 2) improvement of impaired consciousness. 3) improvement of QOL. Compensation period (16 weeks later): 1) improvement of citrullinemia and oxidative stress 2) improvement of QOL, 3) improvement of appetite habit. Neonatal intrahepatic cholestasis caused by citrin deficiency: 1) improvement of cholestasis and citrullinemia 2) catch up of body weight
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath